Phase I and pharmacokinetic trial of weekly CPT-11

Journal of Clinical Oncology

Volumn 11, Issue 11, 1993, Pages 2194-2204

  Rothenberg, M L ^a   Kuhn, J G ^a   Burris III, H A ^a   Nelson, J ^a   Eckardt, J R ^a   Tristan Morales, M ^a   Hilsenbeck, S G ^a   Weiss, G R ^a   Smith, L S ^a   Rodriguez, G I ^a   Rock, M K ^a   Von Hoff, D D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CAMPTOTHECIN; CAMPTOTHECIN SODIUM; IRINOTECAN; LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; UTERUS CANCER;

EID: 0027140524     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.11.2194     Document Type: Article

References (0)